Advanced Oncology Second Opinion - IHC Interpretation and Consultation (10 Markers)

A comprehensive consultation package, provided by a multidisciplinary team of pathologists, involves the critical review and analytical integration of immunohistochemistry (IHC) results for ten or more markers on a tissue sample. This includes a detailed analysis of expression patterns, assessment of synergism or antagonism between marker groups (such as B and T cell markers, differentiation markers, proliferation indicators, and therapeutic receptors), and contextualization of this data within the latest international classifications (such as WHO) and treatment guidelines to produce a highly specialized final consultation report.